美国 · SEC FORM 4
Xeris Biopharma Holdings, Inc.
XERS · Nasdaq · CIK 0001867096 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
29 同一窗口内观察到的 Form 4 交易行
20 sales · 9 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-06-13 · McCulloch Kevin.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 7,202,379
- 上期报告
- 8,058,977
- 日均成交量
- 4,146,096
- 回补天数
- 1.7
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-06-13 | McCulloch Kevin | 买入 (P) | Common Stock | 25,000 | USD 4.38 | USD 109,500 | SEC 申报 ↗ |
| 2024-08-12 | Schmid John P. | 买入 (P) | Common Stock | 4,515 | USD 2.25 | USD 10,159 | SEC 申报 ↗ |
| 2024-08-09 | Schmid John P. | 买入 (P) | Common Stock | 4,285 | USD 2.37 | USD 10,155 | SEC 申报 ↗ |
| 2024-05-10 | Schmid John P. | 买入 (P) | Common Stock | 5,400 | USD 1.91 | USD 10,314 | SEC 申报 ↗ |
| 2024-03-14 | Schmid John P. | 买入 (P) | Common Stock | 4,500 | USD 2.16 | USD 9,720 | SEC 申报 ↗ |
| 2023-11-27 | SHERMAN JEFFREY W | 买入 (P) | Common Stock | 5,400 | USD 1.87 | USD 10,098 | SEC 申报 ↗ |
| 2023-11-20 | Pieper Steven | 买入 (P) | Common Stock | 28,000 | USD 1.95 | USD 54,600 | SEC 申报 ↗ |
| 2023-11-20 | HALKUFF DAWN | 买入 (P) | Common Stock | 5,410 | USD 1.84 | USD 9,954 | SEC 申报 ↗ |
| 2023-11-17 | Shannon John Patrick Jr | 买入 (P) | Common Stock | 30,769 | USD 1.64 | USD 50,461 | SEC 申报 ↗ |
| 2023-11-16 | Schmid John P. | 买入 (P) | Common Stock | 6,500 | USD 1.51 | USD 9,815 | SEC 申报 ↗ |
| 2023-11-14 | PERSKY MARLA | 买入 (P) | Common Stock | 6,370 | USD 1.58 | USD 10,065 | SEC 申报 ↗ |
| 2023-08-09 | Edick Paul R | 买入 (P) | Common Stock | 10,000 | USD 2.38 | USD 23,800 | SEC 申报 ↗ |
| 2022-12-13 | Edick Paul R | 买入 (P) | Common Stock | 20,000 | USD 1.45 | USD 29,000 | SEC 申报 ↗ |
| 2022-05-12 | Edick Paul R | 买入 (P) | Common Stock | 100,000 | USD 1.40 | USD 140,000 | SEC 申报 ↗ |
| 2021-11-15 | Edick Paul R | 买入 (P) | Common Stock | 20,000 | USD 2.28 | USD 45,600 | SEC 申报 ↗ |
Form 4 申报证据
68 transaction lines in the latest 365-day window; 226 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Pieper Steven | 卖出 (S) | Common Stock | 5,000 | USD 9.41 | USD 47,036 | SEC 申报 ↗ |
| 2026-10-01 | McCulloch Kevin | 卖出 (S) | Common Stock | 15,000 | USD 9.41 | USD 141,120 | SEC 申报 ↗ |
| 2026-10-01 | Hecht Beth | 卖出 (S) | Common Stock | 16,666 | USD 9.41 | USD 156,792 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Pieper Steven | 卖出 (S) | Common Stock | 5,000 | USD 9.41 | USD 47,036 | SEC 申报 ↗ |
| 2026-10-01 | McCulloch Kevin | 卖出 (S) | Common Stock | 15,000 | USD 9.41 | USD 141,120 | SEC 申报 ↗ |
| 2026-10-01 | Hecht Beth | 卖出 (S) | Common Stock | 16,666 | USD 9.41 | USD 156,792 | SEC 申报 ↗ |
| 2026-09-28 | McCulloch Kevin | 卖出 (S) | Common Stock | 25,000 | USD 10.00 | USD 250,000 | SEC 申报 ↗ |
| 2026-09-01 | Pieper Steven | 卖出 (S) | Common Stock | 5,000 | USD 8.50 | USD 42,500 | SEC 申报 ↗ |
| 2026-09-01 | McCulloch Kevin | 卖出 (S) | Common Stock | 15,000 | USD 8.49 | USD 127,350 | SEC 申报 ↗ |
| 2026-09-01 | Hecht Beth | 卖出 (S) | Common Stock | 16,666 | USD 8.49 | USD 141,494 | SEC 申报 ↗ |
| 2026-08-12 | Pieper Steven | 卖出 (S) | Common Stock | 5,000 | USD 8.50 | USD 42,500 | SEC 申报 ↗ |
| 2026-08-03 | McCulloch Kevin | 卖出 (S) | Common Stock | 15,000 | USD 8.02 | USD 120,300 | SEC 申报 ↗ |
| 2026-08-03 | Hecht Beth | 卖出 (S) | Common Stock | 16,666 | USD 8.01 | USD 133,495 | SEC 申报 ↗ |
| 2026-08-01 | Shannon John Patrick Jr | 代扣税 (F) | Common Stock | 36,645 | USD 8.08 | USD 296,092 | SEC 申报 ↗ |
| 2026-08-01 | McCulloch Kevin | 代扣税 (F) | Common Stock | 21,918 | USD 8.08 | USD 177,097 | SEC 申报 ↗ |
| 2026-07-07 | Pieper Steven | 卖出 (S) | Common Stock | 27,600 | USD 8.52 | USD 235,152 | SEC 申报 ↗ |
| 2026-07-06 | Pieper Steven | 卖出 (S) | Common Stock | 17,400 | USD 8.50 | USD 147,900 | SEC 申报 ↗ |
| 2026-07-01 | McCulloch Kevin | 卖出 (S) | Common Stock | 90,000 | USD 8.03 | USD 722,700 | SEC 申报 ↗ |
| 2026-07-01 | KREHER NERISSA | 奖励／授予 (A) | Common Stock | 33,582 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Hecht Beth | 卖出 (S) | Common Stock | 16,666 | USD 8.03 | USD 133,828 | SEC 申报 ↗ |
| 2026-06-04 | PERSKY MARLA | 奖励／授予 (A) | Common Stock | 24,193 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Kong Garheng | 奖励／授予 (A) | Common Stock | 24,193 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | JOHNSON JOHN | 卖出 (S) | Common Stock | 15,000 | USD 6.09 | USD 91,350 | SEC 申报 ↗ |
| 2026-06-04 | JOHNSON JOHN | 奖励／授予 (A) | Common Stock | 24,193 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | HALKUFF DAWN | 卖出 (S) | Common Stock | 20,000 | USD 6.09 | USD 121,800 | SEC 申报 ↗ |
| 2026-06-04 | HALKUFF DAWN | 奖励／授予 (A) | Common Stock | 24,193 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Brady James Aloysius | 奖励／授予 (A) | Common Stock | 24,193 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE | 卖出 (S) | Common Stock | 16,000 | USD 6.09 | USD 97,440 | SEC 申报 ↗ |
| 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE | 奖励／授予 (A) | Common Stock | 24,193 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | PERSKY MARLA | 卖出 (S) | Common Stock | 15,500 | USD 5.90 | USD 91,450 | SEC 申报 ↗ |
| 2026-06-01 | Hecht Beth | 卖出 (S) | Common Stock | 16,667 | USD 6.06 | USD 101,002 | SEC 申报 ↗ |
| 2026-05-01 | Hecht Beth | 卖出 (S) | Common Stock | 16,667 | USD 6.23 | USD 103,835 | SEC 申报 ↗ |
| 2026-04-01 | Hecht Beth | 卖出 (S) | Common Stock | 16,667 | USD 5.99 | USD 99,835 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | XERS |
| CIK | 0001867096 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 226 transaction lines from 2021-10-05 to 2026-10-01 19 P purchase lines · 38 S sale lines · 169 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.